NCT07439523

Brief Summary

This study investigates the effects of combining Active Recovery (AR) and Foam Rolling (FR) on blood lactate, heart rate, and muscle soreness in competitive 400-meter sprint athletes. Twenty healthy athletes will be randomly assigned to one of two groups: Experimental group: Active Recovery + Foam Rolling Control group: Active Recovery only All participants will perform a simulated 400-meter sprint. Following the sprint, both groups perform 5 minutes of light jogging (Active Recovery). Subsequently, participants in the experimental group will perform 10 minutes of foam rolling on the quadriceps, hamstring, and gastrocnemius muscles. Measurements include: Blood lactate: pre- and post-recovery Heart rate: baseline, pre-exercise, post-recovery Muscle soreness (VAS 0-10): quadriceps, hamstring, gastrocnemius at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise The study aims to determine whether adding foam rolling to active recovery improves post-exercise physiological and perceptual recovery markers. Participants will not be informed of their group assignment to reduce bias; only the investigators will know. All procedures will take place at the Athletics Track, Surabaya State University, Indonesia. Ethical approval has been obtained from Komite Etik Penelitian Kesehatan STIKES Guna Bangsa Yogyakarta (Ethical Approval No: 009/KEPK/II/2026).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

February 18, 2026

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

1 day

First QC Date

February 17, 2026

Last Update Submit

May 2, 2026

Conditions

Keywords

Active RecoveryFoam RollingBlood LactatecombinationHeart RateMuscle SorenessAthleticsQuadricepsHamstringGastrocnemiusTrack and Field

Outcome Measures

Primary Outcomes (3)

  • Blood Lactate Concentration

    Blood lactate will be measured using a finger-prick lactate analyzer immediately before and after the recovery protocol following a 400-meter sprint.

    Pre-recovery and post-recovery (15 minutes)

  • Heart Rate

    Heart rate will be recorded using a Polar H-10 chest strap monitor at baseline, immediately before the sprint, and immediately after the recovery protocol.

    Baseline, pre-exercise, and post-recovery (15 minutes after completion of recovery protocol)

  • Muscle Soreness VAS (Quadriceps, Hamstring, Gastrocnemius)

    Muscle soreness will be assessed using a visual analog scale (0-10) for quadriceps, hamstring, and gastrocnemius muscles at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise.

    Baseline, pre-exercise, post-recovery (15 minutes after completion of recovery protocol), 1 hour, 24 hours post-exercise

Study Arms (2)

Active Recovery + Foam Rolling

EXPERIMENTAL

Participants perform a 400-meter sprint followed by 5 minutes of active recovery (light jogging). Subsequently, participants in this group perform 10 minutes of foam rolling focusing on quadriceps, hamstring, and gastrocnemius muscles. Blood lactate is measured pre- and post-recovery. Heart rate is recorded at baseline, pre-exercise, and post-recovery using a chest strap monitor. Muscle soreness is assessed using a visual analog scale (0-10) at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise.

Behavioral: Active Recovery + Foam Rolling

Active Recovery Only

ACTIVE COMPARATOR

Participants perform a 400-meter sprint followed by 5 minutes of active recovery (light jogging) only. Blood lactate is measured pre- and post-recovery. Heart rate is recorded at baseline, pre-exercise, and post-recovery using a chest strap monitor. Muscle soreness is assessed using a visual analog scale (0-10) at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise.

Behavioral: Active Recovery Only

Interventions

Participants perform a 400-meter sprint followed by 5 minutes of active recovery (light jogging). Subsequently, participants perform 10 minutes of foam rolling on quadriceps, hamstring, and gastrocnemius muscles. Blood lactate is measured pre- and post-recovery. Heart rate is recorded at baseline, pre-exercise, and post-recovery using a chest strap monitor. Muscle soreness is assessed using a visual analog scale (0-10) at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise.

Active Recovery + Foam Rolling

Participants perform a 400-meter sprint followed by 5 minutes of active recovery (light jogging) only. Blood lactate is measured pre- and post-recovery. Heart rate is recorded at baseline, pre-exercise, and post-recovery using a chest strap monitor. Muscle soreness is assessed using a visual analog scale (0-10) at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise.

Active Recovery Only

Eligibility Criteria

Age18 Years - 23 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male university athletes specializing in 400-meter sprint.
  • Age between 18 and 23 years.
  • Currently training regularly and free from musculoskeletal injuries.
  • Willing to provide written informed consent

You may not qualify if:

  • History of cardiovascular, metabolic, or musculoskeletal disorders.
  • Use of performance-enhancing drugs or supplements in the past 3 months.
  • Inability to perform maximal sprint due to injury or other medical conditions.
  • Refusal or inability to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitas Negeri Surabaya - Athletics Track

Surabaya, East Java, Indonesia

Location

Related Publications (6)

  • Konrad A, Nakamura M, Bernsteiner D, Tilp M. The Accumulated Effects of Foam Rolling Combined with Stretching on Range of Motion and Physical Performance: A Systematic Review and Meta-Analysis. J Sports Sci Med. 2021 Jul 1;20(3):535-545. doi: 10.52082/jssm.2021.535. eCollection 2021 Sep.

    PMID: 34267594BACKGROUND
  • Pearcey GE, Bradbury-Squires DJ, Kawamoto JE, Drinkwater EJ, Behm DG, Button DC. Foam rolling for delayed-onset muscle soreness and recovery of dynamic performance measures. J Athl Train. 2015 Jan;50(1):5-13. doi: 10.4085/1062-6050-50.1.01. Epub 2014 Nov 21.

    PMID: 25415413BACKGROUND
  • Hendricks S, Hill H, Hollander SD, Lombard W, Parker R. Effects of foam rolling on performance and recovery: A systematic review of the literature to guide practitioners on the use of foam rolling. J Bodyw Mov Ther. 2020 Apr;24(2):151-174. doi: 10.1016/j.jbmt.2019.10.019. Epub 2019 Nov 2.

    PMID: 32507141BACKGROUND
  • D'Amico A, Paolone V. The Effect of Foam Rolling on Recovery Between two Eight Hundred Metre Runs. J Hum Kinet. 2017 Jun 22;57:97-105. doi: 10.1515/hukin-2017-0051. eCollection 2017 Jun.

    PMID: 28713462BACKGROUND
  • Bibic E, Barisic V, Katanic B, Chernozub A, Trajkovic N. Acute Effects of Foam Rolling and Stretching on Physical Performance and Self-Perceived Fatigue in Young Football Players. J Funct Morphol Kinesiol. 2025 Jan 17;10(1):36. doi: 10.3390/jfmk10010036.

    PMID: 39846677BACKGROUND
  • Wiewelhove T, Doweling A, Schneider C, Hottenrott L, Meyer T, Kellmann M, Pfeiffer M, Ferrauti A. A Meta-Analysis of the Effects of Foam Rolling on Performance and Recovery. Front Physiol. 2019 Apr 9;10:376. doi: 10.3389/fphys.2019.00376. eCollection 2019.

    PMID: 31024339BACKGROUND

MeSH Terms

Conditions

Myalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesMusculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants were blinded to group allocation; only investigators were aware. Randomization was performed prior to the study day. On the day of testing, participants completed a 400-meter sprint followed by 5 minutes of active recovery. Subsequently, participants in the experimental group were called to perform foam rolling, while control participants continued active recovery only.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two groups: Experimental group (Active Recovery + Foam Rolling) or Control group (Active Recovery only). Each participant will perform a simulated 400-meter sprint. Blood lactate will be measured pre- and post-recovery using a finger-prick lactate analyzer. Heart rate will be recorded at baseline, pre-exercise, and post-recovery using a Polar H-10. Muscle soreness of the quadriceps, hamstring, and gastrocnemius will be assessed using a visual analog scale (0-10) at baseline, pre-exercise, post-recovery, 1 hour, and 24 hours post-exercise. All procedures will be conducted at the Athletics Track, State University of Surabaya, Indonesia.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Sport Science Department

Study Record Dates

First Submitted

February 17, 2026

First Posted

February 27, 2026

Study Start

February 18, 2026

Primary Completion

February 19, 2026

Study Completion

February 19, 2026

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to the small sample size (n=20) and the sensitive nature of physiological and subjective measures, including blood lactate, heart rate, and muscle soreness scores. Data confidentiality and participant privacy will be strictly maintained

Locations